Jiapeng Lu

5.9k total citations · 2 hit papers
71 papers, 3.0k citations indexed

About

Jiapeng Lu is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jiapeng Lu has authored 71 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 16 papers in Public Health, Environmental and Occupational Health and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jiapeng Lu's work include Blood Pressure and Hypertension Studies (20 papers), Cardiovascular Health and Risk Factors (10 papers) and Lipoproteins and Cardiovascular Health (8 papers). Jiapeng Lu is often cited by papers focused on Blood Pressure and Hypertension Studies (20 papers), Cardiovascular Health and Risk Factors (10 papers) and Lipoproteins and Cardiovascular Health (8 papers). Jiapeng Lu collaborates with scholars based in China, United States and Australia. Jiapeng Lu's co-authors include Harlan M. Krumholz, Lixin Jiang, Yuan Lu, Chaoqun Wu, Xi Li, Shengshou Hu, Erica S. Spatz, Shuang Hu, Elías Mossialos and Frederick A. Masoudi and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Jiapeng Lu

64 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)

2017 783 citations Jiapeng Lu, Yuan Lu et al. The Lancet profile →
The primary health-care system in China

2017 689 citations Xi Li, Jiapeng Lu et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiapeng Lu China	23	1.1k	576	552	521	414	71	3.0k
Guillermo García-García Mexico	27	620 0.5×	472 0.8×	326 0.6×	706 1.4×	537 1.3×	162	5.8k
Panniyammakal Jeemon India	31	1.2k 1.1×	364 0.6×	157 0.3×	531 1.0×	403 1.0×	121	3.0k
Shuchi Anand United States	29	735 0.7×	301 0.5×	162 0.3×	358 0.7×	279 0.7×	93	3.0k
Adrianna Murphy United Kingdom	20	598 0.5×	524 0.9×	217 0.4×	234 0.4×	270 0.7×	69	2.0k
John W. Stanifer United States	23	407 0.4×	317 0.6×	219 0.4×	282 0.5×	269 0.6×	45	2.8k
Perviz Asaria United Kingdom	13	1.1k 1.0×	495 0.9×	111 0.2×	521 1.0×	323 0.8×	16	2.9k
Shuang Hu China	22	464 0.4×	425 0.7×	425 0.8×	136 0.3×	237 0.6×	86	2.1k
Pedro Ordúñez United States	30	1.0k 0.9×	542 0.9×	124 0.2×	438 0.8×	186 0.4×	104	2.5k
R Beaglehole New Zealand	27	897 0.8×	881 1.5×	178 0.3×	1.1k 2.1×	450 1.1×	66	4.1k
Jennifer Hirst United Kingdom	19	539 0.5×	432 0.8×	93 0.2×	358 0.7×	439 1.1×	45	4.0k

Countries citing papers authored by Jiapeng Lu

Since Specialization

Citations

This map shows the geographic impact of Jiapeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiapeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiapeng Lu more than expected).

Fields of papers citing papers by Jiapeng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiapeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiapeng Lu. The network helps show where Jiapeng Lu may publish in the future.

Co-authorship network of co-authors of Jiapeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiapeng Lu. A scholar is included among the top collaborators of Jiapeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiapeng Lu. Jiapeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Li, et al.. (2025). The impact of oral microbiota changes on the prognosis of patients with tracheostomy after craniocerebral trauma. Current Problems in Surgery. 66. 101739–101739.

Liu, Xuan, et al.. (2025). Cost-effectiveness of cardiovascular risk assessment and management among adults with hypertension in China: A modelling study. American Journal of Preventive Cardiology. 22. 101007–101007.

Dong, Weiwei, et al.. (2025). Recent Progress of Sterol Regulatory Element-binding Proteins Role in Atherosclerosis. Current Atherosclerosis Reports. 27(1). 74–74.

Lu, Jiapeng, Haibo Zhang, Bowang Chen, et al.. (2024). Association and its population heterogeneities between low-density lipoprotein cholesterol and all-cause and cardiovascular mortality: A population-based cohort study. Chinese Medical Journal. 137(17). 2075–2083. 1 indexed citations

Chen, Bowang, Yi Han, Jiapeng Lu, et al.. (2024). Prognostic Value of a Multi-mRNA Signature for 1-Year All-Cause Death in Hospitalized Patients With Heart Failure With a Preserved Ejection Fraction. Circulation Heart Failure. 17(6). e011118–e011118. 2 indexed citations

Bai, Xueke, Yang Yang, Jianlan Cui, et al.. (2024). Healthy lifestyle, statin, and mortality in people with high CVD risk: A nationwide population-based cohort study. SHILAP Revista de lepidopterología. 17. 100635–100635. 6 indexed citations

Zhang, Haibo, Jiapeng Lu, Jing Li, et al.. (2024). Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: A cluster randomized controlled trial for hypertension management in primary care. American Heart Journal. 273. 90–101. 2 indexed citations

Wang, Yunfeng, Chaoqun Wu, Jiapeng Lu, et al.. (2023). Influence of Socioeconomic Gender Inequality on Sex Disparities in Prevention and Outcome of Cardiovascular Disease: Data From a Nationwide Population Cohort in China. Journal of the American Heart Association. 12(20). e030203–e030203. 4 indexed citations

Yang, Yang, Jiapeng Lu, Jianlan Cui, et al.. (2023). Cohort Profile: ChinaHEART (Health Evaluation And risk Reduction through nationwide Teamwork) Cohort. International Journal of Epidemiology. 52(5). e273–e282. 23 indexed citations

10.

Su, Xiaoming, et al.. (2023). Age‐Related Trends in the Predictive Value of Carotid Intima‐Media Thickness for Cardiovascular Death: A Prospective Population‐Based Cohort Study. Journal of the American Heart Association. 12(13). e029656–e029656. 9 indexed citations

11.

Lu, Jiapeng, Guiyuan Han, Xiaoying Liu, et al.. (2023). Association of high-density lipoprotein cholesterol with all-cause and cause-specific mortality in a Chinese population of 3.3 million adults: a prospective cohort study. The Lancet Regional Health - Western Pacific. 42. 100874–100874. 30 indexed citations

12.

Wu, Chaoqun, Jiamin Liu, Lihua Zhang, et al.. (2021). Development and validation of a risk prediction model for in-hospital major cardiovascular events in patients hospitalised for acute myocardial infarction. BMJ Open. 11(5). e042506–e042506. 4 indexed citations

13.

Mu, Lin, Guohai Zhou, Chaoqun Wu, et al.. (2021). Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018. Circulation Cardiovascular Quality and Outcomes. 14(6). e007292–e007292. 56 indexed citations

14.

Zhang, Xingyi, Jiapeng Lu, Chaoqun Wu, et al.. (2021). Healthy lifestyle behaviours and all-cause and cardiovascular mortality among 0.9 million Chinese adults. International Journal of Behavioral Nutrition and Physical Activity. 18(1). 162–162. 47 indexed citations

15.

Gao, Yan, Xueke Bai, Jiapeng Lu, et al.. (2021). Prognostic Value of Multiple Circulating Biomarkers for 2-Year Death in Acute Heart Failure With Preserved Ejection Fraction. Frontiers in Cardiovascular Medicine. 8. 779282–779282. 23 indexed citations

16.

Yan, Yan, Xiao Wang, Jincheng Guo, et al.. (2020). Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. American Heart Journal. 227. 19–30. 2 indexed citations

17.

Li, Xi, Jiapeng Lu, Shuang Hu, et al.. (2017). The primary health-care system in China. The Lancet. 390(10112). 2584–2594. 689 indexed citations breakdown →

18.

Lu, Jiapeng, Nicholas S. Downing, Chaoqun Wu, et al.. (2016). Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot. BMJ Open. 6(1). e010200–e010200. 92 indexed citations

19.

Spatz, Erica S., Xianyan Jiang, Jiapeng Lu, et al.. (2015). Qingdao Port Cardiovascular Health Study: a prospective cohort study. BMJ Open. 5(12). e008403–e008403. 4 indexed citations

20.

Lu, Jiapeng, Youxin Wang, Ling Zhang, et al.. (2012). The Genetic Associations and Epistatic Effects of the CCR5 Promoter and CCR2 -V64I Polymorphisms on Susceptibility to HIV-1 Infection in a Northern Han Chinese Population. Genetic Testing and Molecular Biomarkers. 16(12). 1369–1375. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact